Document ID: 1006245

Text:
2.3Capitalization. The authorized capital stock of the Company, as of October 2, 2017, consisted of 50,000,000 shares of Common Stock, $1.00 par value per share, of which 6,932,570 shares were issued and outstanding and 5,000,000 shares of Preferred Stock, no par value per share, none of which is outstanding. All of the issued and outstanding shares of Common Stock have been duly authorized, validly issued, fully paid, and nonassessable and have been issued and sold in compliance in all material respects with all federal and state securities laws. None of the outstanding shares of Common Stock was issued and sold in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company. There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its Subsidiaries other than those described in the SEC Documents. The descriptions of the Companys equity incentive plans, and the equity awards granted thereunder, set forth in the SEC Documents accurately and fairly present in all material respects the information required to be shown with respect to such plans and awards. The Companys Amended and Restated Articles of Incorporation, as amended (the Articles of Incorporation), as in effect on the date hereof, and the Companys Amended and Restated Bylaws (the Bylaws) as in effect on the date hereof, are each filed as exhibits to the SEC Documents and no amendment or modification of either the Articles of Incorporation or the Bylaws, each as in effect on the date hereof, has been approved by, or has been presented to, the shareholders or the Board of Directors of the Company. There are no securities or instruments issued by or to which the Company is a party containing anti- dilution or similar provisions that will be triggered by the issuance of the Shares.

Named Entities:
21
25
Shares
31
34
Price
42
46
Shares
53
57
Shares
260
262
Title
268
270
Title
287
287
Title
290
290
Title
317
319
Title
322
322
Title

Tokenized Text:
2
.
3Capitalization
.
The
authorized
capital
stock
of
the
Company
,
as
of
October
2
,
2017
,
consisted
of
50
,
000
,
000
shares
of
Common
Stock
,
$
1
.
00
par
value
per
share
,
of
which
6
,
932
,
570
shares
were
issued
and
outstanding
and
5
,
000
,
000
shares
of
Preferred
Stock
,
no
par
value
per
share
,
none
of
which
is
outstanding
.
All
of
the
issued
and
outstanding
shares
of
Common
Stock
have
been
duly
authorized
,
validly
issued
,
fully
paid
,
and
nonassessable
and
have
been
issued
and
sold
in
compliance
in
all
material
respects
with
all
federal
and
state
securities
laws
.
None
of
the
outstanding
shares
of
Common
Stock
was
issued
and
sold
in
violation
of
any
preemptive
rights
,
rights
of
first
refusal
or
other
similar
rights
to
subscribe
for
or
purchase
securities
of
the
Company
.
There
are
no
authorized
or
outstanding
options
,
warrants
,
preemptive
rights
,
rights
of
first
refusal
or
other
rights
to
purchase
,
or
equity
or
debt
securities
convertible
into
or
exchangeable
or
exercisable
for
,
any
capital
stock
of
the
Company
or
any
of
its
Subsidiaries
other
than
those
described
in
the
SEC
Documents
.
The
descriptions
of
the
Companys
equity
incentive
plans
,
and
the
equity
awards
granted
thereunder
,
set
forth
in
the
SEC
Documents
accurately
and
fairly
present
in
all
material
respects
the
information
required
to
be
shown
with
respect
to
such
plans
and
awards
.
The
Companys
Amended
and
Restated
Articles
of
Incorporation
,
as
amended
(
the
Articles
of
Incorporation
)
,
as
in
effect
on
the
date
hereof
,
and
the
Companys
Amended
and
Restated
Bylaws
(
the
Bylaws
)
as
in
effect
on
the
date
hereof
,
are
each
filed
as
exhibits
to
the
SEC
Documents
and
no
amendment
or
modification
of
either
the
Articles
of
Incorporation
or
the
Bylaws
,
each
as
in
effect
on
the
date
hereof
,
has
been
approved
by
,
or
has
been
presented
to
,
the
shareholders
or
the
Board
of
Directors
of
the
Company
.
There
are
no
securities
or
instruments
issued
by
or
to
which
the
Company
is
a
party
containing
anti
-
dilution
or
similar
provisions
that
will
be
triggered
by
the
issuance
of
the
Shares
.